Research and analysis

Genetically Modified Organisms: Bavarian Nordic Inc. (11/R44/01)

Details of the consent for Bavarian Nordic Inc. (formerly BN ImmunoTherapeutics Inc.) to release genetically modified organisms.


11/R44/01: Consent variation (09 December 2014)

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.

11/R44/01: Consent variation (16 November 2013)

11/R44/01: Consent variation (10 December 2012)

11/R44/01: Consent (8 January 2012)

11/R44/01: Part A

11/R44/01: Part B


Consent documents for Bavarian Nordic Inc. (formerly BN ImmunoTherapeutics Inc.), to release genetically modified organisms for research purposes.

Each consent granted includes:

  • consent letter (confirming consent and outlining any conditions)
  • part A(1): Information required under schedule 1 of the Genetically Modified Organisms (Deliberate Release) regulations 2002.
  • part A(2-6): (If applicable) Details of related previous releases, including any data, results and risks.
  • part B: Information about the release application to be included on the public register

ACRE’s advice

Published 22 November 2013
Last updated 4 February 2015 + show all updates
  1. Added 11/R44/01: Consent variation (9 December 2014)
  2. First published.